14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide

C33H57NO4 — CID 70126302

IUPAC14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide
SMILESC[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2[C@@H](OCCCCCCCCCCCCCC(N)=O)C[C@]2(C)[C@@H](O)CC[C@@H]12
InChIInChI=1S/C33H57NO4/c1-32-20-19-25(35)22-24(32)15-16-26-27-17-18-29(36)33(27,2)23-28(31(26)32)38-21-13-11-9-7-5-3-4-6-8-10-12-14-30(34)37/h24,26-29,31,36H,3-23H2,1-2H3,(H2,34,37)/t24-,26-,27-,28-,29-,31+,32-,33-/m0/s1
InChIKeyWSHGTBKHQBAKIY-ZTGWXCRFSA-N
MW531.82 g/mol
LogP7.12
Rot. Bonds15

About 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide

14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide (PubChem CID 70126302) has the molecular formula C33H57NO4 and a molecular weight of 531.82 g/mol. Its IUPAC name is 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide.

Molecular Properties

Compound Name14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide
PubChem CID70126302
Molecular FormulaC33H57NO4
Molecular Weight531.82 g/mol
Exact Mass531.43
IUPAC Name14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide
SMILESC[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2[C@@H](OCCCCCCCCCCCCCC(N)=O)C[C@]2(C)[C@@H](O)CC[C@@H]12
InChIInChI=1S/C33H57NO4/c1-32-20-19-25(35)22-24(32)15-16-26-27-17-18-29(36)33(27,2)23-28(31(26)32)38-21-13-11-9-7-5-3-4-6-8-10-12-14-30(34)37/h24,26-29,31,36H,3-23H2,1-2H3,(H2,34,37)/t24-,26-,27-,28-,29-,31+,32-,33-/m0/s1
InChIKeyWSHGTBKHQBAKIY-ZTGWXCRFSA-N
XLogP7.12
TPSA89.62 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds15
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500531.82
LogP ≤ 57.12
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide?
The IUPAC name of 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide (CID 70126302) is 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide.
What is the SMILES notation for 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide?
The canonical SMILES for 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide is C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2[C@@H](OCCCCCCCCCCCCCC(N)=O)C[C@]2(C)[C@@H](O)CC[C@@H]12.
What is the InChIKey of 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide?
The InChIKey is WSHGTBKHQBAKIY-ZTGWXCRFSA-N. The full InChI is InChI=1S/C33H57NO4/c1-32-20-19-25(35)22-24(32)15-16-26-27-17-18-29(36)33(27,2)23-28(31(26)32)38-21-13-11-9-7-5-3-4-6-8-10-12-14-30(34)37/h24,26-29,31,36H,3-23H2,1-2H3,(H2,34,37)/t24-,26-,27-,28-,29-,31+,32-,33-/m0/s1.
What are the key properties of 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide?
14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide has a molecular weight of 531.82 g/mol, XLogP of 7.12, 15 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 14-[[(5S,8S,9S,10S,11S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-yl]oxy]tetradecanamide is sourced from PubChem (CID 70126302), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).